2026-525714-59-00Not yet recruitingPhase 1/2
SNIPER-LTFU: Long-term follow-up study of patients administered with RR001 in the interventional Parent SNIPER study
Source: EU CTIS (euclinicaltrials.eu) · Last updated 9 Oct 2026
Brief summary (registry, in English)
To assess the long term safety profile (93 months LTFU period) of patients who completed SNIPER study.
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- First submitted
- 9 Jul 2026
- Start date
- 1 Sept 2026
- Lead sponsor
- Eir Biotherapies S.r.l.
- Diseases
- Pancreatic cancer
- EU CT number
- 2026-525714-59-00
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 18
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
AI-kivonat: who the study is looking for
Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people who took part in the SNIPER study, were treated with RR001 and finished its end-of-study visit. They are followed for long-term safety.
- Age
- 18 years or older
- Sex
- All sexes
- Earlier treatment
- Must have been treated with RR001 in the SNIPER study and completed its End of Study visit, whatever the treatment result.
Main reasons for not taking part
- Cannot be contacted for follow-up or cannot come to the site for standard of care activities
- Pregnant or breast feeding women
Read by machine on 9 Nov 2026.
Who cannot take part
Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.
Other
- Inability to be contacted for follow-up and to come to the site for SOC (Standard of Care) activities
- Female patients with pregnancy or breast feeding
Who the study is looking for
- Patients who participated in SNIPER study and have been treated by RR001
- Patients who completed the SNIPER End of Study visit, regardless of treatment outcome
- Patients who signed informed consent for long-term follow-up and data collection in accordance with GDPR and who are able to comply with study requirements
- For all patients with childbearing age or not surgically sterile, agreement to use highly effective and adequate method of contraception for at least 12 months following RR001 administration (including both females of childbearing potential and males with partners of childbearing potential)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Azienda Ospedaliero - Universitaria di Modena | Modena | Italy | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.